Dermatology · Portland, OR
NPI
1740320068
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9495 SW Locust St Ste A
Portland, OR, 97223
Phone (036) 369-0115
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
323 services
Medicare patients, 2024
80
Average age 76
Drug cost, 2024
$567K
211 prescriptions
Company payments, 2025
$243K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin D Ehst was code 99213 (office e&m - established), 95 times for 65 patients. In total Benjamin D Ehst billed 323 services in 17 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 95 | 65 | $62.58 | $5,945 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 56 | 33 | $12.26 | $686 |
| 17000 Destruction Skin Lesion | Office | 42 | 25 | $41.36 | $1,737 |
| 99214 Office E&M - Established | Office | 31 | 22 | $84.40 | $2,617 |
| 17003 Destruction Skin Lesion | Office | 29 | 16 | $5.25 | $152 |
| 17110 Destruction Skin Lesion | Office | 20 | 16 | $86.45 | $1,729 |
| 11102 Skin Biopsy | Office | 15 | 12 | $75.88 | $1,138 |
By year: 2022 $15K for 319 services; 2023 $18K for 341 services; 2024 $16K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin D Ehst prescribed most often to Medicare patients was Clobetasol Propionate, with 27 prescriptions and refills. In total Benjamin D Ehst wrote 211 Medicare prescriptions that cost $567K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 27 | 33 | 15 | $2,674 |
| Skyrizi Pen Risankizumab-Rzaa | 17 | 46 | Under 11 | $356K |
| Methotrexate Methotrexate Sodium | 15 | 26 | Under 11 | $239 |
| Bimzelx Bimekizumab-Bkzx | 13 | 13 | Under 11 | $189K |
| Triamcinolone Acetonide Generic | 12 | 13 | Under 11 | $111 |
| Acitretin Generic | 11 | 12 | Under 11 | $5,788 |
Brand drugs: 39 claims; generic drugs: 172 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin D Ehst $243K ($243K in general payments such as food, travel and fees) from 23 companies. The largest payer was Lilly USA, LLC with $89K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 81 | $89K |
| UCB, Inc. UCB.BR | 43 | $29K |
| Organon LLC OGN | 25 | $27K |
| Abbvie Inc. ABBV | 36 | $25K |
| Regeneron Healthcare Solutions, Inc. REGN | 24 | $17K |
| Novartis Pharmaceuticals Corporation NVS | 32 | $14K |
| LEO Pharma Inc. | 25 | $13K |
| LEO Pharma AS | 2 | $9,503 |
| Genzyme Corporation SNY | 8 | $8,997 |
| Incyte Corporation INCY | 10 | $5,100 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.